Clinical Trial Update: A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus [Phase 1, Phase 2]

View source ↗

Summary

This is a first-in-human study of ARO-ALK7 in adults with obesity, with and without Type 2 diabetes mellitus. The trial is in Phase 1/2 and currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• ARO-ALK7

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Obesity, Diabetes Mellitus, Type 2 | Phase 1, Phase 2 | Status: RECRUITING